F255-0635 Screening compound: 7-methoxy-N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-1H,4H,5H-benzo[g]indazole-3-carboxamide

F255-0635 Screening compound: 7-methoxy-N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-1H,4H,5H-benzo[g]indazole-3-carboxamide
F255-0635 Screening compound: 7-methoxy-N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-1H,4H,5H-benzo[g]indazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F255-0635
7-methoxy-N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-1H,4H,5H-benzo[g]indazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F255-0635

Molecular Formula

C29H27N5O2 (C29 H27 N5 O2)

Compound Name

7-methoxy-N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-1H,4H,5H-benzo[g]indazole-3-carboxamide

IUPAC name

7-methoxy-N-{4-[2-(5-methyl-1H-13-benzodiazol-2-yl)ethyl]phenyl}-1H4H5H-benzo[g]indazole-3-carboxamide

SMILES

Cc(cc1)cc2c1[nH]c(CCc(cc1)ccc1NC(c1n[nH]c-3c1CCc1c3ccc(OC)c1)=O)n2

InChI

InChI=1S/C29H27N5O2/c1-17-3-13-24-25(15-17)32-26(31-24)14-6-18-4-8-20(9-5-18)30-29(35)28-23-11-7-19-16-21(36-2)10-12-22(19)27(23)33-34-28/h3-5,8-10,12-13,15-16H,6-7,11,14H2,1-2H3,(H,30,35)(H,31,32)(H,33,34)

InChI Key

MISMSHYWAGYSBL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14946277

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.57

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.302

Distribution Coefficient, logD

6.286

Water Solubility, LogSw

-5.48

Polar Surface Area

74.925

Acid Dissociation Constant (pKa)

6.86

Base Dissociation Constant (pKb)

5.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.70

F255-0635 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Protein-Protein Interaction Library (218420 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Ion Channels Focused Library (26372 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Nervous system
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • Kinases
  • Ion Channels
  • Phosphatases

References: we are preparing a list of scientific research reports with F255-0635 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F255-0635?
Check Price and Availability of F255-0635, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F255-0635 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F255-0635
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F255-0635
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F255-0635 available by request